PMPC Holds Its First Reporting Period Review: Reflecting on Progress and Looking Ahead

On 13–14 October 2026, the Center of Excellence for Precision Medicine in Pediatric Care (PMPC) project held its first Reporting Period Review (RP1 Review) at the Children’s Clinical University Hospital (CCUH) in Riga, Latvia. The two-day meeting brought together PMPC team members, the European Commission’s Project Officer and external experts to assess the progress achieved during the first 18 months of the project and discuss priorities for the next phase.

Created: 4.11.2026.
Updated: 4.11.2026.

Throughout the two intensive days, consortium representatives presented the work carried out across the project’s key areas and discussed its scientific and operational development. The review covered research and governance structures, ethics and data management, research infrastructure, clinical research capabilities, rapid molecular diagnostics, the transfer of translational know-how in novel cell therapies, as well as dissemination and communication activities.

 

An important part of the programme focused on the development of PMPC’s research and clinical infrastructure. The visiting representatives and experts had the opportunity to explore the hospital’s Clinical Trial Unit, Genomics laboratories and Biobank facilities, as well as visit the construction site of the future Health Advancement Centre building. These facilities represent an important foundation for strengthening paediatric research and advancing precision medicine in clinical practice.

 

The second day focused on lessons learned during the first reporting period, identified risks and mitigation measures, and the next steps in project implementation. A dedicated scientific discussion also explored PMPC’s long-term development, research capacity building, institutional mindset and sustainability.

 

We are grateful to the European Commission’s Project Officer Maria Isabel Farfan Camacho and external experts Joan Comella and Joan Comella for their time, valuable insights and recommendations throughout the review. Their feedback provides important guidance for strengthening our approach, addressing the challenges ahead and ensuring that the project continues to progress towards its commitments and objectives.

 

At the heart of PMPC is a child. Every research activity, diagnostic innovation and investment in infrastructure is ultimately driven by one shared ambition: to make more precise, timely and personalised diagnostic and treatment opportunities available to children. This is what gives meaning to our work and what continues to drive the entire PMPC team forward.

PMPC First Reporting Period Review

PMPC RP1 Review
PMPC RP1 Review
PMPC RP1 Review
PMPC RP1 Review
PMPC RP1 Review
PMPC RP1 Review

no 6